A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

Not specified

Study Completion Date

January 31, 2004

Conditions
HIV Infections
Interventions
DRUG

Ritonavir

DRUG

Lamivudine

DRUG

Zidovudine

Trial Locations (12)

10016

NYU Med. Ctr., Dept. of Medicine, New York

Nyu Ny Nichd Crs, New York

10032

Columbia IMPAACT CRS, New York

Incarnation Children's Ctr., New York

10037

Harlem Hosp. Ctr. NY NICHD CRS, New York

19104

The Children's Hosp. of Philadelphia IMPAACT CRS, Philadelphia

20060

Howard Univ. Washington DC NICHD CRS, Washington D.C.

38105

St. Jude/UTHSC CRS, Memphis

70112

Tulane/LSU Maternal/Child CRS, New Orleans

90806

Long Beach Memorial Med. Ctr., Miller Children's Hosp., Long Beach

92103

UCSD Maternal, Child, and Adolescent HIV CRS, San Diego

02115

HMS - Children's Hosp. Boston, Div. of Infectious Diseases, Boston

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH